BACKGROUND: Vitamin D increases cathelicidin production, and might alter mortality due to tuberculosis (TB) in human immunodeficiency virus (HIV) coinfection. However, due to abundant sun exposure, vita min D levels might be excellent among Ugandans with HIV and TB. METHODS: We measured 25(OH)D and calcium levels in 50 HIV-negative, 50 HIV-infected and 50 TB-HIV coinfected Ugandan adults. RESULTS: Mean ± standard deviation 25(OH)D levels were 26 ± 7 ng/ml in HIV-negative, 28 ± 11 ng/ml in HIV-infected and 24 ± 11 ng/ml in TB-HIV co-infected adults (P > 0.05 all comparisons). Vitamin D deficiency (< 12 ng/ml) was present in 10% of the HIV-infected subjects, 12% of the TB-HIV co-infected and none of the healthy controls (P = 0.03 for healthy vs. TB, P > 0.05 for other comparisons); 20% of the healthy controls, 22% of the HIV-positive and 38% of the TB-HIV co-infected subjects (P = 0.047 for healthy vs. TB, P > 0.05 for other comparisons) had suboptimal vitamin D levels (< 20 ng/ml). No participant had hypercalcemia. Serum 25(OH)D levels correlated positively with body mass index (r = 0.22, P = 0.03) and serum calcium levels (r = 0.18, P = 0.03). CONCLUSIONS: Ugandan HIV-infected adults with and without TB commonly had suboptimal vitamin D levels. Clinical trials are needed to evaluate the effect of vitamin D on health outcomes in HIV-infected patients with low vitamin D levels.
BACKGROUND:Vitamin D increases cathelicidin production, and might alter mortality due to tuberculosis (TB) in humanimmunodeficiency virus (HIV) coinfection. However, due to abundant sun exposure, vita min D levels might be excellent among Ugandans with HIV and TB. METHODS: We measured 25(OH)D and calcium levels in 50 HIV-negative, 50 HIV-infected and 50 TB-HIV coinfected Ugandan adults. RESULTS: Mean ± standard deviation 25(OH)D levels were 26 ± 7 ng/ml in HIV-negative, 28 ± 11 ng/ml in HIV-infected and 24 ± 11 ng/ml in TB-HIV co-infected adults (P > 0.05 all comparisons). Vitamin D deficiency (< 12 ng/ml) was present in 10% of the HIV-infected subjects, 12% of the TB-HIV co-infected and none of the healthy controls (P = 0.03 for healthy vs. TB, P > 0.05 for other comparisons); 20% of the healthy controls, 22% of the HIV-positive and 38% of the TB-HIV co-infected subjects (P = 0.047 for healthy vs. TB, P > 0.05 for other comparisons) had suboptimal vitamin D levels (< 20 ng/ml). No participant had hypercalcemia. Serum 25(OH)D levels correlated positively with body mass index (r = 0.22, P = 0.03) and serum calcium levels (r = 0.18, P = 0.03). CONCLUSIONS: Ugandan HIV-infected adults with and without TB commonly had suboptimal vitamin D levels. Clinical trials are needed to evaluate the effect of vitamin D on health outcomes in HIV-infectedpatients with low vitamin D levels.
Authors: Robert H Glew; Michael J Crossey; Jup Polanams; Henry I Okolie; Dorothy J VanderJagt Journal: J Natl Med Assoc Date: 2010-06 Impact factor: 1.798
Authors: Christian Wejse; Victor F Gomes; Paulo Rabna; Per Gustafson; Peter Aaby; Ida M Lisse; Paul L Andersen; Henning Glerup; Morten Sodemann Journal: Am J Respir Crit Care Med Date: 2009-01-29 Impact factor: 21.405
Authors: Alexandra V Yamshchikov; Nirali S Desai; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha Journal: Endocr Pract Date: 2009 Jul-Aug Impact factor: 3.443
Authors: Carolien J P Van Den Bout-Van Den Beukel; Lydia Fievez; Meta Michels; Fred C G J Sweep; Ad R M M Hermus; Marjolein E W Bosch; David M Burger; Bert Bravenboer; Peter P Koopmans; André J A M Van Der Ven Journal: AIDS Res Hum Retroviruses Date: 2008-11 Impact factor: 2.205
Authors: Anne C Looker; Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley Journal: Am J Clin Nutr Date: 2008-12 Impact factor: 7.045
Authors: Fiona Havers; Laura Smeaton; Nikhil Gupte; Barbara Detrick; Robert C Bollinger; James Hakim; Nagalingeswaran Kumarasamy; Adriana Andrade; Parul Christian; Javier R Lama; Thomas B Campbell; Amita Gupta Journal: J Infect Dis Date: 2014-05-05 Impact factor: 5.226
Authors: Daniel S Kiggundu; Edrisa Mutebi; Davis Kibirige; Rebecca Boxer; Barbara Kakande; Brian K Kigozi; Elly Katabira Journal: BMC Endocr Disord Date: 2015-10-05 Impact factor: 2.763
Authors: D J Sloan; H C Mwandumba; M Kamdolozi; D Shani; B Chisale; J Dutton; S H Khoo; T J Allain; G R Davies Journal: Int J Tuberc Lung Dis Date: 2015-08 Impact factor: 2.373
Authors: Fiona P Havers; Barbara Detrick; Sandra W Cardoso; Sima Berendes; Javier R Lama; Patcharaphan Sugandhavesa; Noluthando H Mwelase; Thomas B Campbell; Amita Gupta Journal: PLoS One Date: 2014-04-21 Impact factor: 3.240